Whole-body PET
What Is Whole-Body PET?
Whole-body PET is a positron emission tomography imaging technique that captures the distribution of a radiotracer throughout the entire body simultaneously, rather than scanning limited axial segments sequentially. The approach is enabled by long axial field-of-view (LAFOV) detector systems, where rings of scintillator crystals extend 70 centimeters or more along the patient axis, covering head and torso or the full body in a single acquisition. The technique draws on nuclear medicine, particle physics, and detector engineering, and it has redefined sensitivity and dynamic range in clinical and research PET imaging.
Conventional PET scanners have axial fields of view of roughly 15 to 26 centimeters, requiring table motion to cover extended anatomy. Whole-body PET eliminates this limitation by detecting coincidence events from the entire imaged volume at once, yielding sensitivity gains proportional to the extended detector solid angle. The uEXPLORER system at the University of California Davis, developed with United Imaging Healthcare and featuring a 194 cm axial field of view, was among the first clinical whole-body PET instruments and demonstrated that total-body PET scanning can achieve diagnostic image quality with approximately 5 percent of the radiotracer dose used in conventional protocols.
Detector Physics and Sensitivity
The fundamental sensitivity advantage in whole-body PET arises because a positron annihilation event anywhere in the body can be detected by a coincidence pair drawn from the entire detector ring assembly, not just the ring segment nearest the annihilation site. This geometric gain scales roughly with the square of the ratio of the new to old axial field-of-view lengths. Scintillator materials used in modern LAFOV systems, including lutetium oxyorthosilicate (LSO) and its variants, deliver fast timing resolution necessary for time-of-flight (TOF) reconstruction, which further improves signal-to-noise by localizing each annihilation along its line of response. Timing resolution below 250 picoseconds is achievable in current systems and continues to improve as detector and electronics designs advance.
Image Reconstruction
Whole-body PET datasets are substantially larger than those from conventional scanners, and reconstruction algorithms must handle the full three-dimensional sinogram without simplifications that assume a short axial extent. Ordered subsets expectation maximization (OSEM) with TOF information, extended for the LAFOV geometry, is the standard clinical reconstruction approach. Attenuation correction relies on co-registered CT or MRI data acquired on the same imaging platform. Deep learning-based reconstruction methods have also been adapted for LAFOV PET to reduce noise in low-dose acquisitions and shorten reconstruction times, an active area in IEEE Transactions on Medical Imaging and related journals.
Dynamic and Kinetic Imaging
A major research application of whole-body PET is dynamic kinetic modeling across multiple organs simultaneously. Because all organs are within the detector field at the same moment, tracer uptake curves can be measured in the heart, liver, kidneys, and tumor sites during the same scan without table movement. This enables pharmacokinetic analyses previously impossible with standard scanners, including the measurement of inter-organ tracer exchange and blood-pool input functions from the aorta. The Springer EJNMMI Physics review of total body PET surveys the kinetic modeling frameworks and the hardware design trade-offs that make these measurements practical.
Applications
Whole-body PET has applications in a range of fields, including:
- Oncology staging and whole-body metastatic disease assessment with reduced radiation dose
- Systemic pharmacokinetic studies of novel radiolabeled drugs across multiple organ compartments
- Cardiovascular and neuroscience research requiring simultaneous cardiac and brain tracer kinetics
- Pediatric oncology where dose minimization is especially critical
- Infectious disease imaging, including tracking of inflammation across organ systems